172 related articles for article (PubMed ID: 28425130)
41. Possible predictors of histopathological response to neoadjuvant chemoradiotherapy for rectal cancer.
Farkas R; Pozsgai E; Schally AV; Szigeti A; Szigeti E; Laszlo Z; Papp A; Gomori E; Mangel L; Horvath PO; Bellyei S
J Cancer Res Clin Oncol; 2012 Mar; 138(3):387-95. PubMed ID: 22160161
[TBL] [Abstract][Full Text] [Related]
42. T2 weighted signal intensity evolution may predict pathological complete response after treatment for rectal cancer.
Kluza E; Rozeboom ED; Maas M; Martens M; Lambregts DM; Slenter J; Beets GL; Beets-Tan RG
Eur Radiol; 2013 Jan; 23(1):253-61. PubMed ID: 22777621
[TBL] [Abstract][Full Text] [Related]
43. A prognostic model comprising pT stage, N status, and the chemokine receptors CXCR4 and CXCR7 powerfully predicts outcome in neoadjuvant resistant rectal cancer patients.
D'Alterio C; Avallone A; Tatangelo F; Delrio P; Pecori B; Cella L; Pelella A; D'Armiento FP; Carlomagno C; Bianco F; Silvestro L; Pacelli R; Napolitano M; Iaffaioli RV; Scala S
Int J Cancer; 2014 Jul; 135(2):379-90. PubMed ID: 24375277
[TBL] [Abstract][Full Text] [Related]
44. Expression of hypoxia-inducible factor 1α predicts clinical outcome after preoperative hyperthermo-chemoradiotherapy for locally advanced rectal cancer.
Shioya M; Takahashi T; Ishikawa H; Sakurai H; Ebara T; Suzuki Y; Saitoh J; Ohno T; Asao T; Kuwano H; Nakano T
J Radiat Res; 2011; 52(6):821-7. PubMed ID: 22104271
[TBL] [Abstract][Full Text] [Related]
45. Glucose transporter 1 (GLUT1) of anaerobic glycolysis as predictive and prognostic values in neoadjuvant chemoradiotherapy and laparoscopic surgery for locally advanced rectal cancer.
Shim BY; Jung JH; Lee KM; Kim HJ; Hong SH; Kim SH; Sun DS; Cho HM
Int J Colorectal Dis; 2013 Mar; 28(3):375-83. PubMed ID: 22847606
[TBL] [Abstract][Full Text] [Related]
46. Increased CD133 expression after preoperative chemoradiotherapy in rectal cancers other than mucin-rich tumors.
Lin CH; Chen WT; Liu CH; Tsai HP; Wu CC; Chai CY
Virchows Arch; 2012 May; 460(5):447-53. PubMed ID: 22453233
[TBL] [Abstract][Full Text] [Related]
47. Histopathology of residual rectal carcinoma following preoperative radiochemotherapy.
Micev M; Micev-Cosić M; Todorović V; Krsmanović M; Krivokapić Z; Popović M; Barisić G; Marković V; Jelić-Radosević L; Popov I
Acta Chir Iugosl; 2004; 51(2):99-108. PubMed ID: 15771300
[TBL] [Abstract][Full Text] [Related]
48. Modified neoadjuvant rectal score as a novel prognostic model for rectal cancer patients who underwent chemoradiotherapy.
Kawai K; Ozaki K; Nakano D; Dejima A; Ise I; Nakamori S; Kato H; Natsume S; Takao M; Yamaguchi T; Ishihara S
Int J Clin Oncol; 2024 Jul; 29(7):1012-1018. PubMed ID: 38592641
[TBL] [Abstract][Full Text] [Related]
49. Quantitative measures of visceral adiposity and body mass index in predicting rectal cancer outcomes after neoadjuvant chemoradiation.
Clark W; Siegel EM; Chen YA; Zhao X; Parsons CM; Hernandez JM; Weber J; Thareja S; Choi J; Shibata D
J Am Coll Surg; 2013 Jun; 216(6):1070-81. PubMed ID: 23523147
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of histological regression grading systems in the neoadjuvant therapy of rectal cancer: do they have prognostic impact?
Vallböhmer D; Bollschweiler E; Brabender J; Wedemeyer I; Grimminger PP; Metzger R; Schröder W; Gutschow C; Hölscher AH; Drebber U
Int J Colorectal Dis; 2012 Oct; 27(10):1295-301. PubMed ID: 22614681
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of the prognostic impact of pathologic tumor regression grade on patients with colorectal cancer after preoperative chemoradiotherapy.
Nakao E; Honda M; Uesugi N; Osakabe M; Sato A; Todate Y; Yaegashi M; Takano Y; Sasaki A; Kono K; Sugai T
J Surg Oncol; 2024 Jun; 129(8):1521-1533. PubMed ID: 38691656
[TBL] [Abstract][Full Text] [Related]
52. Predictive value of Ki67 and p53 in locally advanced rectal cancer: correlation with thymidylate synthase and histopathological tumor regression after neoadjuvant 5-FU-based chemoradiotherapy.
Jakob C; Liersch T; Meyer W; Becker H; Baretton GB; Aust DE
World J Gastroenterol; 2008 Feb; 14(7):1060-6. PubMed ID: 18286688
[TBL] [Abstract][Full Text] [Related]
53. Molecular diagnosis of response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer.
Chen Z; Duldulao MP; Li W; Lee W; Kim J; Garcia-Aguilar J
J Am Coll Surg; 2011 Jun; 212(6):1008-1017.e1. PubMed ID: 21458303
[TBL] [Abstract][Full Text] [Related]
54. Laboratory blood data have a significant impact on tumor response and outcome in preoperative chemoradiotherapy for advanced rectal cancer.
Yasuda K; Sunami E; Kawai K; Nagawa H; Kitayama J
J Gastrointest Cancer; 2012 Jun; 43(2):236-43. PubMed ID: 21365477
[TBL] [Abstract][Full Text] [Related]
55. PDCD4 as a predictor of sensitivity to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.
Dou X; Wang RB; Meng XJ; Yan HJ; Jiang SM; Zhu KL; Xu XQ; Chen D; Song XR; Mu DB
Asian Pac J Cancer Prev; 2014; 15(2):825-30. PubMed ID: 24568503
[TBL] [Abstract][Full Text] [Related]
56. Retrospective Evaluation of the Efficacy of Total Neoadjuvant Therapy and Chemoradiotherapy Neoadjuvant Treatment in Relation to Surgery in Patients with Rectal Cancer.
Bratu LD; Schenker M; Stovicek PO; Schenker RA; Mehedințeanu AM; Berisha TC; Donoiu A; Mogoantă SȘ
Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674302
[No Abstract] [Full Text] [Related]
57. An individualized conditional survival calculator for patients with rectal cancer.
Bowles TL; Hu CY; You NY; Skibber JM; Rodriguez-Bigas MA; Chang GJ
Dis Colon Rectum; 2013 May; 56(5):551-9. PubMed ID: 23575393
[TBL] [Abstract][Full Text] [Related]
58. Preoperative radiochemotherapy is successful also in patients with locally advanced rectal cancer who have intrinsically high apoptotic tumours.
Gosens MJ; Dresen RC; Rutten HJ; Nieuwenhuijzen GA; van der Laak JA; Martijn H; Tan-Go I; Nagtegaal ID; van den Brule AJ; van Krieken JH
Ann Oncol; 2008 Dec; 19(12):2026-32. PubMed ID: 18664561
[TBL] [Abstract][Full Text] [Related]
59. β-catenin and Her2/neu expression in rectal cancer: association with histomorphological response to neoadjuvant therapy and prognosis.
Drebber U; Madeja M; Odenthal M; Wedemeyer I; Mönig SP; Brabender J; Bollschweiler E; Hölscher AH; Schneider PM; Dienes HP; Vallböhmer D
Int J Colorectal Dis; 2011 Sep; 26(9):1127-34. PubMed ID: 21538055
[TBL] [Abstract][Full Text] [Related]
60. [Pathological staging and response evaluation of rectal carcinoma].
Wittekind C; Oberschmid B
Chirurg; 2012 May; 83(5):423-9. PubMed ID: 22422083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
